83
Views
6
CrossRef citations to date
0
Altmetric
Review

Sexual function in hypertensive patients receiving treatment

&
Pages 447-455 | Published online: 24 Dec 2022

References

  • AuerbachSGittlemanMMazzuASimultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasiaUrology200464998100315533493
  • BansalSSexual dysfunction in hypertensive men: a critical review of the literatureHypertension1988121103294176
  • BenetAEMelmanAThe epidemiology of erectile dysfunctionUrol Clin North Am1995226997097483123
  • BillupsKLEndothelial dysfunction as a common link between erectile dysfunction and cardiovascular diseaseCurrent Sexual Health Reports2004113741
  • BlumentalsWAGomez-CamineroAJooSShould erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort studyInt J Impot Res200416350314985780
  • BohlenJGHeldJPSandersonMOHeart rate, rate-pressure product and oxygen uptake during four sexual activitiesArch Intern Med198414174586476990
  • BrockGBDrug-induced male sexual dysfunction. An updateDrug Saf19938414268329147
  • BrockHMcMahonCGChenKKEfficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analysesJ Urol20021681332612352386
  • BruckertEGiralPHeshmatiHMMen treated with hypolipidaemic drugs complain more frequently of erectile dysfunctionJ Clin Pharm Ther19962189948809645
  • CarvajalALeridaMTSanchezAACE inhibitors and impotence: a case series from Spanish drug monitoring systemDrug Saf19951313017576264
  • CardilloCKilcoyneCMQuyyumiAAA selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertensionCirculation19989785169521333
  • CheitlinMDHutterAMBrindisRGACC/AHA Expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular diseaseJ Am Coll Cardiol199933273829935041
  • CorbinJDPharmacology of phosphodiesterase-5 inhibitorsInt J Clin Prct2002564539
  • DeBuskRFSexual activity triggering myocardial infarction: one less thing to worry aboutJAMA1996275144788618373
  • DeBuskRDroryYGoldsteinIManagement of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus PanelAm J Cardiol2000861758110913479
  • DeBuskRFEvaluating the cardiovascular tolerance to sexAm J Cardiol200086suppl51F56F
  • DerbyCAMohrBAGoldsteinIModifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?Urology200056302610925098
  • DusingREffect of the angiotensin II antagonist valsartan on sexual function in hypertensive menBlood Press Suppl20032293414761074
  • EmmickJTStueweSRMitchellMOverview of the cardiovascular effects of tadalafilEur Heart J20024H32H47
  • FeldmanHAGoldsteinIHatzichristouDGImpotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging StudyJ Urol199415154618254833
  • FerrarioCMLevyPSexual function in patients with hypertension: implications for therapyJ Clin Hyper tens20024424432
  • GazzarusoCGiordanettiSDe AmiciERelationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetes patientsCirculation200411022615210604
  • GreinerKAWeigelJWErectile dysfunctionAm Fam Physician1996541675828857789
  • GresserUGleiterCHErectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil. Review of the literatureEur J Med Res200274354612435622
  • GrossGJSildenafil and endothelial dysfunction in humansCirculation2005111721315710774
  • HaleTMOkabeHHeatonJPAntihypertensive drugs induce structural remodeling of penile vasculatureJ Urol20011667394511458127
  • JacksonGStable angina: drugs, angioplasty or surgery?Eur Heart J199718B2B109152663
  • JacksonGErectile dysfunction and cardiovascular diseaseInt J Clin Pract199953363810695101
  • JacksonGSexual intercourse and stable angina pectorisAm J Cardiol200086suppl35F37F10867089
  • JohannesCBAraujoABFeldmanHAIncidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging StudyJ Urol2000163460310647654
  • KaiserDRBillupsKMasonCImpaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular diseaseJ Am Coll Cardiol2004431798414736434
  • KeeneLCDaviesPHDrug-related erectile dysfunctionAdverse Drug React Toxicol Rev19991852410401520
  • KimSWPaickJParkDWPotential predictors of asymptomatic ischemic heart disease in patients with vasculogenic erectile dysfunctionUrology200158441511549496
  • KlonerRAJarowJPErectile dysfunction and sildenafil citrate and cardiologistsAm J Cardiol1999835768210073864
  • KlonerRAHypertension as a risk for erectile dysfunction: implications for sildenafil useJ Clin Hypertens20002336
  • KlonerRABrownMPrisantLMEffect of sildenafil in patients with erectile dysfunction taking antihypertensive therapyAm J Hypertens20011451524
  • KlonerRAErectile dysfunction and atherosclerosisCurr Atheroscler Rep2002439740112162940
  • KlonerRAHutterAHEmmickJTTime course of the interaction between tadalafil and nitratesJ Am Coll Cardiol2003a4218556014642699
  • KlonerRAMitchellMEmmickJTCardiovascular effects of tadalafil in patients on common antihypertensive therapiesAm J Cardiol2003b9247M57M
  • KlonerRAMohanPNorenbergCCardiovascular safety of vardenafil, a potent, highly selective PDE-5 inhibitor in patients with erectile dysfunction: an analysis of five placebo controlled trialsPharmacol Ther20022213716
  • KlonerRACardiovascular effects of 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunctionCirculation200411031495515533876
  • KlonerRAJacksonGEmmickJTInteraction between the phosphodiesterase 5 inhibitor, tadalafil, and the two α-blockers doxazosin and tamsulosin in healthy normotensive menJ Urol200417219354015540759
  • KostisJBJacksonGRosenRSexual dysfunction and cardiac risk (the second Princeton Consensus Conference)Am J Cardiol2005963132116018863
  • LangfordHGRockfoldRWWassertheil-SmollerSEffect of weight loss on thiazide produced erectile problems in menTrans Am CLin Climatol Assoc198910119042486442
  • LevineLADiagnosis and treatment of erectile dysfunctionAm J Med20001093S12S11137497
  • LlisterriJLLozano VidalJVAznar VicenteJSexual dysfunction in hypertensive patients treated with lorsatanAm J Med Sci20013213364111370797
  • LudmerPLSelwynAPShookTLParadoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteriesN Engl J Med1986315104610513093861
  • MacMahonSPetroRCutlerJBlood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasLancet1990335765741969518
  • McVaryKTCarrierSWessellsHSmoking and erectile dysfunction: evidence based analysisJ Urol200116616243211586190
  • MoulikPKHypertension, anti-hypertensive drug therapy and erectile dysfunction in diabetesDiabet Med200320290312675642
  • MullerJEMittlemanMAMaclureMTriggering myocardial infarction by sexual activityJAMA1996275140598618365
  • MullerJEKaufmannPGLuepkerRVMechanisms precipitating acute cardiac events. Review and recommendations of an NHLBI WorkshopCirculation199796323399386197
  • NabelEGGanzPGordonJBDilation of normal and constriction of atherosclerotic coronary arteries caused by cold pressure testCirculation19887743522826047
  • NavaELuscherTFEndothelium-derived vasoactive factors in hypertension: nitric oxide and endothelinJ Hypertens199513suppl 2S39S48
  • NicholsDJMuirheadGJHarnessJAPharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionalityBr J Pharmacol2002535S12S
  • NicolosiAEpidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunctionUrology200361201612559296
  • NIH Consensus Development Panel on ImpotenceImpotenceJAMA199327083908510302
  • NurnbergHGTreatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trialJAMA2003289566412503977
  • NusbaumMRErectile dysfunction: prevalence, etiology, and major risk factorsJ Am Osteopath Assoc2002102S1S612572634
  • ParkKShinJWOhJKRestoration of erectile capacity in normotensive aged rats by modulation of angiotensin receptor type 1J Androl20052612312815611576
  • PomaraGMorelliGPomaraSCardiovascular parameter changes in patients with erectile dysfunction using PDE-5 inhibitors: a study with sildenafil and vardenafilJ Androl200425625915223851
  • RalphDMcNicholasTUK management guidelines for erectile dysfunctionBMJ200032149950210948037
  • ReffelmannTKlonerRATherapeutic potential of phosphodiesterase 5 inhibitors for cardiovascular diseaseCirculation20031082394412860892
  • ReffelmannTKlonerRABroderickGAErectile dysfunction. Assessing risk and managing the cardiac patientOral pharmacotherapy for male sexual dysfunction. A guide to clinical management2005aTotowa, New JerseyHumana Press Inc.199220
  • ReffelmannTKlonerRAPharmacotherapy of erectile dysfunction: focus on cardiovascular safetyExpert Opin Drug Saf2005b45314015934858
  • RizviKHampsonJPHarveyJNDo lipid-lowering drugs cause erectile dysfunction? A systemativ reviewFam Pract20021995811818357
  • RomeoJHSeftelADMadhumZTSexual function in men with diabetes type 2: association with glycemic controlJ Urol200016673945
  • RothAPrevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli menClin Cardiol200326253012539809
  • SchachterMErectile dysfunction and lipid disordersCurr Med Res Opin200016S9S1211329828
  • SchwarzERRodriguezJSex and the heartInt J Impot Res200517Suppl 1S4616391542
  • SairamKKulinskayaEBousteadGBPrevalence of undiagnosed diabetes mellitus in male erectile dysfunctionBJU Int200188687111446849
  • SolomonHManJWierzbickiASErectile dysfunction: cardiovascular risk and the role of the cardiologistInt J Clin Pract20035796912661790
  • SteinRAThe effect of exercise training on heart rate during sexual activity in the post-myocardial infarction patientCirculation19775573840849632
  • SternSSymptoms other than chest pain may be important in the diagnosis of “silent ischemia” or “the sound of silence”Circulation2005111e435e43715967853
  • TaddeiSVirdisAMatteiPVasodilation to acetylcholine in primary and secondary forms of hypertensionHypertension199321929338505103
  • TobbliJEStellaIMazzaONDifferent effect of losartan and amlodipine on penile structures in male spontaneously hypertensive ratsAm J Nephrol20042461462315591797
  • ThompsonIMTangenCMGoodmanPJErectile dysfunction and subsequent cardiovascular diseaseJAMA20052942996300216414947
  • UenoMThe so-called coition deathJpn J Leg Med196317330335
  • VardiYKlerinLNassarSEffects of sildenafil citrate (Viagra) on blood pressure in normotensive and hypertensive menUrology2002597475211992853
  • WalczakMKLokhandwalaNHodgeMBPrevalence of cardiovascular risk factors in erectile dysfunctionJ Gend Specif Med20026192112503222
  • WallisRMCorbinJDFrancisSHTissue distribution of phosphodiesterase families and the effect of sildenafil on tissue cyclic nucleotides, platelet function and contractile responses of trabeculae carneae and aortic ringsAm J Cardiol1999833C12C
  • WebbDJFreedstoneSAllenMJSildenafil citrate and blood-pressure lowering drugs: results of drug interaction studies with an organic nitrate and a calcium channel antagonistAm J Cardiol19998321C28C10073779
  • WysowskiDKFarinasESwartzLComparison of reported and expected deaths in sildenafil (Viagra) usersAm J Cardiol2002891331412031744
  • ZusmanRMMoralesAGlaserDBOverall cardiovascular profile of sildenafil citrateAm J Cardiol19998335C44C